vs
优尼威（CLMB）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是优尼威的2.0倍（$382.2M vs $193.8M），优尼威净利率更高（3.6% vs 3.1%，领先0.5%），优尼威同比增速更快（19.8% vs 17.4%），过去两年优尼威的营收复合增速更高（44.8% vs 12.8%）
优尼威解决方案是一家全球化学品与原料分销商，同时可为客户提供各类增值服务，在行业内拥有广泛的全球布局与专业服务能力。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
CLMB vs LFST — 直观对比
营收规模更大
LFST
是对方的2.0倍
$193.8M
营收增速更快
CLMB
高出2.4%
17.4%
净利率更高
CLMB
高出0.5%
3.1%
两年增速更快
CLMB
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $193.8M | $382.2M |
| 净利润 | $7.0M | $11.7M |
| 毛利率 | 15.4% | — |
| 营业利润率 | 4.9% | 4.7% |
| 净利率 | 3.6% | 3.1% |
| 营收同比 | 19.8% | 17.4% |
| 净利润同比 | -0.1% | 264.1% |
| 每股收益（稀释后） | $1.51 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLMBLFST
| Q4 25 | $193.8M | $382.2M | ||
| Q3 25 | $161.3M | $363.8M | ||
| Q2 25 | $159.3M | $345.3M | ||
| Q1 25 | $138.0M | $333.0M | ||
| Q4 24 | $161.8M | $325.5M | ||
| Q3 24 | $119.3M | $312.7M | ||
| Q2 24 | $92.1M | $312.3M | ||
| Q1 24 | $92.4M | $300.4M |
净利润CLMBLFST
| Q4 25 | $7.0M | $11.7M | ||
| Q3 25 | $4.7M | $1.1M | ||
| Q2 25 | $6.0M | $-3.8M | ||
| Q1 25 | $3.7M | $709.0K | ||
| Q4 24 | $7.0M | $-7.1M | ||
| Q3 24 | $5.5M | $-6.0M | ||
| Q2 24 | $3.4M | $-23.3M | ||
| Q1 24 | $2.7M | $-21.1M |
毛利率CLMBLFST
| Q4 25 | 15.4% | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 16.9% | — | ||
| Q4 24 | 19.3% | — | ||
| Q3 24 | 20.3% | — | ||
| Q2 24 | 20.2% | — | ||
| Q1 24 | 18.4% | — |
营业利润率CLMBLFST
| Q4 25 | 4.9% | 4.7% | ||
| Q3 25 | 4.3% | 2.0% | ||
| Q2 25 | 5.0% | -0.9% | ||
| Q1 25 | 3.5% | 0.5% | ||
| Q4 24 | 7.2% | 0.3% | ||
| Q3 24 | 7.1% | 0.0% | ||
| Q2 24 | 4.6% | -5.1% | ||
| Q1 24 | 3.8% | -5.6% |
净利率CLMBLFST
| Q4 25 | 3.6% | 3.1% | ||
| Q3 25 | 2.9% | 0.3% | ||
| Q2 25 | 3.7% | -1.1% | ||
| Q1 25 | 2.7% | 0.2% | ||
| Q4 24 | 4.3% | -2.2% | ||
| Q3 24 | 4.6% | -1.9% | ||
| Q2 24 | 3.7% | -7.5% | ||
| Q1 24 | 3.0% | -7.0% |
每股收益（稀释后）CLMBLFST
| Q4 25 | $1.51 | — | ||
| Q3 25 | $1.02 | — | ||
| Q2 25 | $1.30 | — | ||
| Q1 25 | $0.81 | — | ||
| Q4 24 | $1.52 | — | ||
| Q3 24 | $1.19 | — | ||
| Q2 24 | $0.75 | — | ||
| Q1 24 | $0.60 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.6M | $248.6M |
| 总债务越低越好 | — | $282.8M |
| 股东权益账面价值 | $116.6M | $1.5B |
| 总资产 | $460.2M | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资CLMBLFST
| Q4 25 | $36.6M | $248.6M | ||
| Q3 25 | $49.8M | $203.9M | ||
| Q2 25 | $28.6M | $188.9M | ||
| Q1 25 | $32.5M | $134.3M | ||
| Q4 24 | $29.8M | $154.6M | ||
| Q3 24 | $22.1M | $102.6M | ||
| Q2 24 | $48.4M | $87.0M | ||
| Q1 24 | $43.6M | $49.5M |
总债务CLMBLFST
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | $1.2M | $288.8M |
股东权益CLMBLFST
| Q4 25 | $116.6M | $1.5B | ||
| Q3 25 | $109.3M | $1.5B | ||
| Q2 25 | $105.2M | $1.5B | ||
| Q1 25 | $95.6M | $1.5B | ||
| Q4 24 | $90.6M | $1.4B | ||
| Q3 24 | $87.7M | $1.4B | ||
| Q2 24 | $79.8M | $1.4B | ||
| Q1 24 | $76.4M | $1.4B |
总资产CLMBLFST
| Q4 25 | $460.2M | $2.2B | ||
| Q3 25 | $376.1M | $2.1B | ||
| Q2 25 | $420.7M | $2.1B | ||
| Q1 25 | $370.1M | $2.1B | ||
| Q4 24 | $469.2M | $2.1B | ||
| Q3 24 | $371.9M | $2.1B | ||
| Q2 24 | $302.8M | $2.1B | ||
| Q1 24 | $298.3M | $2.1B |
负债/权益比CLMBLFST
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | 0.02× | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.9M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | — | $46.6M |
| 自由现金流率自由现金流/营收 | — | 12.2% |
| 资本支出强度资本支出/营收 | — | 2.9% |
| 现金转化率经营现金流/净利润 | -1.70× | 4.93× |
| 过去12个月自由现金流最近4个季度 | — | $110.0M |
8季度趋势，按日历期对齐
经营现金流CLMBLFST
| Q4 25 | $-11.9M | $57.6M | ||
| Q3 25 | $22.2M | $27.3M | ||
| Q2 25 | $-2.2M | $64.4M | ||
| Q1 25 | $8.5M | $-3.1M | ||
| Q4 24 | $16.0M | $62.3M | ||
| Q3 24 | $-3.6M | $22.7M | ||
| Q2 24 | $7.3M | $44.1M | ||
| Q1 24 | $14.0M | $-21.8M |
自由现金流CLMBLFST
| Q4 25 | — | $46.6M | ||
| Q3 25 | — | $17.0M | ||
| Q2 25 | — | $56.6M | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | — | $56.0M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | — | $39.0M | ||
| Q1 24 | — | $-26.9M |
自由现金流率CLMBLFST
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | -3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | 12.5% | ||
| Q1 24 | — | -9.0% |
资本支出强度CLMBLFST
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.7% |
现金转化率CLMBLFST
| Q4 25 | -1.70× | 4.93× | ||
| Q3 25 | 4.73× | 25.34× | ||
| Q2 25 | -0.37× | — | ||
| Q1 25 | 2.30× | -4.36× | ||
| Q4 24 | 2.29× | — | ||
| Q3 24 | -0.66× | — | ||
| Q2 24 | 2.13× | — | ||
| Q1 24 | 5.14× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLMB
| Distribution Segment | $187.9M | 97% |
| Solutions Segment | $6.0M | 3% |
LFST
暂无分部数据
